Article info
PDFEditorial
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?
- Correspondence to Professor Cyrus R Kumana, Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong; hrmekcr{at}hku.hk
Citation
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?
Publication history
- Received December 13, 2016
- Revised March 10, 2017
- Accepted March 13, 2017
- First published April 22, 2017.
Online issue publication
June 28, 2017
Article Versions
- Previous version (22 April 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.